Welcome to our dedicated page for Petiq news (Ticker: PETQ), a resource for investors and traders seeking the latest updates and insights on Petiq stock.
PetIQ, Inc. (PETQ) provides essential health solutions for pets through veterinarian-recommended medications, wellness products, and treats. This news hub offers investors and industry stakeholders centralized access to official updates impacting the company's market position and operational developments.
Track material events through press releases covering quarterly earnings, regulatory filings, product innovations, and strategic partnerships. Our curated collection simplifies monitoring of PetIQ's financial performance, manufacturing expansions, and new product launches in the $140B+ pet care industry.
Key updates include FDA approvals for pet medications, retail distribution agreements, production facility upgrades, and executive leadership changes. Bookmark this page for verified information directly from corporate communications and SEC filings, ensuring informed analysis of PetIQ's growth trajectory.
For comprehensive due diligence on PETQ stock, check back regularly for unfiltered access to operational milestones, financial disclosures, and market expansion initiatives within the competitive pet healthcare sector.
PetIQ announced the appointment of Sheryl Oloughlin and Kim Lefko as independent directors, effective March 2, 2021. This expands the Board from five to seven members. Oloughlin will serve as a Class I director on the Compensation Committee, while Lefko will serve as a Class III director on the Audit Committee. CEO Cord Christensen expressed excitement about their experience in consumer goods, retail, and marketing, which is expected to enhance the company’s strategic growth initiatives in the pet health and wellness sector.
PetIQ, a leader in pet medication and wellness, will participate in the Raymond James 42nd Annual Institutional Investors Conference on March 3, 2021, at 3:00 p.m. EST. The event will be accessible live on the Company’s website. PetIQ offers affordable veterinary products through over 60,000 distribution points and operates the VIP Petcare service platform in over 3,400 locations across 41 states. The Company emphasizes its commitment to delivering quality care and products for pets, reflecting its belief in treating pets as family.
EAGLE, Idaho, Feb. 11, 2021 – PetIQ, a leading pet medication and wellness company (Nasdaq: PETQ), will report its fourth quarter and full year results for 2020 on February 25, 2021, after market close. A conference call hosted by the executive management team will follow at 4:30 p.m. ET the same day, with participation available via phone or live broadcast on the Company’s website. A playback of the call will be accessible until March 11, 2021. PetIQ emphasizes affordable veterinary products through over 60,000 distribution points and operates VIP Petcare in 41 states.
PetIQ (Nasdaq: PETQ), a leading pet medication and wellness company, announced its participation in the Jefferies Virtual West Coast Consumer Conference. The management fireside chat is scheduled for November 17, 2020, at 12:20 p.m. ET. The event can be accessed live on the company’s website under the 'Investors' section.
PetIQ offers a smarter way for pet parents to care for their pets through affordable veterinary products. With over 60,000 distribution points and a national service platform, VIP Petcare, operating in 41 states, the company is committed to enhancing pet wellness.
PetIQ, a pet medication and wellness company, reported its Q3 2020 financial results, showing net sales of $162.1 million, a 12.9% decline from the previous year. Despite a strong year-to-date sales growth of 10.9%, the Services segment faced a significant 51.7% revenue drop to $12.0 million. The net loss increased to $64.5 million, primarily due to a non-cash tax expense. The Company completed the acquisition of Capstar, expecting over $20 million in incremental EBITDA in 2021. Total liquidity stands at approximately $167 million as of September 30, 2020.
PetIQ, a prominent pet medication and wellness company, will announce its third-quarter financial results on November 5, 2020, after the market closes. The company's executive management will host a conference call at 4:30 p.m. ET on the same day to discuss these results. Interested parties can participate by calling designated numbers or by accessing the live broadcast on PetIQ's website. A playback of the call will be available until November 19, 2020. PetIQ serves over 60,000 distribution points and operates a national service platform providing affordable veterinary services.
PetIQ has successfully re-opened approximately 70% of its wellness centers and 60% of its community clinics, with all 37 regional offices now operational. The company aims to re-open 95% of its clinics by the end of Q3 2020. Additionally, 27 new wellness centers under construction are expected to debut in Q4 2020. Recent openings have shown a quick recovery in customer traffic, returning to pre-COVID-19 levels. CEO Cord Christensen expressed optimism about PetIQ’s ability to meet the increasing demand for affordable veterinary care.
PetIQ, Inc. (Nasdaq: PETQ) announced the acquisition of the Capstar® portfolio, effective July 31, 2020. Capstar® is the leading oral OTC flea treatment in the U.S., contributing to PetIQ's strategy to provide affordable pet health solutions. The acquisition includes seven SKUs, solidifying PetIQ's market presence, especially as Capstar® remains the only oral OTC flea treatment for cats. CEO Cord Christensen highlighted the acquisition’s profitability and growth potential, reinforcing PetIQ’s commitment to enhancing pet wellness.
PetIQ, a prominent pet medication and wellness company, will release its second-quarter financial results for the period ending June 30, 2020, on August 6, 2020, post market close. The conference call to discuss these results will commence at 4:30 p.m. ET, accessible via phone for North American listeners at 855-327-6837 and for international listeners at 631-891-4304. The call will also be streamed live on PetIQ's website. A playback will be available until August 27, 2020, with specific dial-in details provided.
PetIQ, a prominent pet medication and wellness company, will participate in the Jefferies Virtual Consumer Conference on June 23, 2020, at 10:30 a.m. ET. The event will be accessible live via the Company's website. PetIQ aims to improve pet health through affordable veterinary products and services, distributed via over 60,000 retail and e-commerce points. Their national service platform, VIP Petcare, offers services in 41 states, underscoring the Company's commitment to pet wellness.
FAQ
What is the current stock price of Petiq (PETQ)?
What is the market cap of Petiq (PETQ)?
